Classical and Delayed Orthostatic Hypotension in Patients With Unexplained Syncope and Severe Orthostatic Intolerance

Parisa Torabi1,2, Fabrizio Ricci1,3, Viktor Hamrefors1,4

  • 1Department of Clinical Sciences, Faculty of Medicine, Clinical Research Center, Lund University, Malmö, Sweden.

Insights

Classical orthostatic hypotension (cOH) patients are older and exhibit distinct neuroendocrine profiles compared to delayed OH (dOH). This study differentiates cOH and dOH, revealing key clinical and hormonal differences in cardiovascular autonomic failure.

Area of Science:

  • Cardiology
  • Neurology
  • Endocrinology

Background:

  • Orthostatic hypotension (OH) is a significant indicator of cardiovascular autonomic failure, causing orthostatic intolerance and syncope.
  • OH is classified into classical (cOH) and delayed (dOH) forms, with limited understanding of their distinct characteristics.
  • This study provides a comprehensive clinical and neuroendocrine evaluation of OH subtypes.

Purpose of the Study:

  • To systematically characterize and compare classical OH (cOH) and delayed OH (dOH) in patients presenting with unexplained syncope.
  • To investigate the differences in clinical presentation, hemodynamic responses, and neuroendocrine profiles between cOH and dOH.
  • To elucidate the pathophysiology underlying these two variants of orthostatic hypotension.

Main Methods:

  • Analysis of 2,167 patients with unexplained syncope and orthostatic intolerance undergoing cardiovascular autonomic testing, including head-up tilt (HUT).
  • Identification and detailed comparison of clinical history, demographics, and hemodynamic variables between cOH and dOH cohorts.
  • Measurement of plasma levels of key neuroendocrine markers (epinephrine, norepinephrine, CT-proAVP, etc.) in supine and HUT positions.

Main Results:

  • 27% of the cohort (248 cOH, 336 dOH) were diagnosed with OH.
  • cOH patients were older, more frequently male, and had higher supine blood pressure, lower eGFR, and more comorbidities like Parkinson's disease and arrhythmias.
  • Neuroendocrine analysis revealed higher supine and HUT CT-proAVP in cOH, greater HUT epinephrine increase in cOH, and a more pronounced norepinephrine increase in dOH.

Conclusions:

  • Classical OH is characterized by older age, supine hypertension, specific comorbidities, and distinct neuroendocrine responses involving vasopressin and epinephrine.
  • The findings highlight significant differences between cOH and dOH, suggesting distinct pathophysiological mechanisms.
  • Understanding these differences is crucial for accurate diagnosis and tailored management of orthostatic hypotension.

Related Concept Videos

Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.8K
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
1.3K
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.4K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
682
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
2.4K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.3K